IV infusion reactions in critical care


Intravenous news: UPI.com report “German researchers suggest some infusion solutions in a common intravenous treatment may cause life-threatening inflammation. The study, published in the Journal of Leukocyte Biology, found a common intravenous treatment used to boost blood pressure in critical patients contains substances called “advanced glycation end products.” This reaction among various proteins occurring after the fluid has been formulated for use is called “post-translational modification.” The researchers suggest screening infusion solutions for post-translational protein modifications and then removing the compounds.”

Click here to read the full story on UPI.com


Comments are closed.